We recently identified an Autism Spectrum Disorder/Intellectual Disability (ASD/ID)-related de novo mutation hotspot in the Rac1 activating GEF1 domain of the protein Trio. Trio is a Rho guanine nucleotide exchange factor (RhoGEF) that is essential for glutamatergic synapse function. An ASD/ID-related mutation identified in Trio's GEF1 domain, Trio D1368V, produces a pathological increase in glutamatergic synaptogenesis, suggesting that Trio is coupled to synaptic regulatory mechanisms that govern glutamatergic synapse formation. However, the molecular mechanisms by which Trio regulates glutamatergic synapses are largely unexplored. Here, using biochemical methods we identify an interaction between Trio and the synaptogenic protein Neuroligin 1 (NLGN1) in the brain. Molecular biological approaches were then combined with super resolution dendritic spine imaging and whole-cell voltage clamp electrophysiology in male and female rats to examine the impact ASD/ID-related Trio mutations have on NLGN1-mediated s...